Volume II provides high-level overviews of the biological agents that are most commonly associated with biodefense activities. Additional chapters present the status quo of antibacterial and antiviral therapy and diagnostic development.
The authors aim to create a multifactorial risk-priority scoring system for Category A BW agents using 10 criteria that include factors relating to disease potentiality, probability of attack, and prevention/intervention methods.
Provides a pathogen-by-pathogen accounting of weapons agents, considering their weapons use/potential and contextualizing that with typical medical microbiology and epidemiology background information.
This article aims to give recommendations for measures to be taken by medical and public health professionals if hemorrhagic fever viruses are used as biological weapons against a civilian population.
This paper aims to highlight the differences between chemical and biological attacks and specify areas of improvement needed in the civilian R&D sphere.
Description of transmission routes/pathways for grouping infectious diseases broadly (food- and water-borne, contact, air-borne, vector-borne, endogenous). Criteria for selection of infective agents that pose biological warfare risk. Rules out a list…
This report assesses the utility of multi-criteria decision analysis (MCDA) and decision support framework (DSF) in assisting the US Department of Agriculture in its reviews of select agents. It uses the method to assess 41 pathogens against 21…
Gives information on updates regarding the Division of Select Agents and Toxins' select agent scoring and ranking system. The review is contextualized by abundant criticism of the 2008 Bioterrorism Risk Assessment for overly complex modeling, lack of…
Outlines the objectives of the Joint Force in response to any BW attack, especially those where physical and physiological protections cannot prevent infection. Provides details about roles and responsibilities within the Joint Force in the event of…
This is the third edition of Medical Aspects of Biological Warfare and aims to highlight the current state of science on individual agents and toxins and general response capabilities to prevent knowledge gaps and serve as a reference source for the…
This report is an historical analysis of US biodefense and bioweapons posture in order to understand the disparity between chemical weapons preparedness and biological weapons preparedness.
The purpose of this handbook is to serve as a concise, pocket-sized manual that can be used in a crisis to guide medical personnel in the prophylaxis and management of biological casualties.
This is a hearing before the Subcommittee on Prevention of Nuclear and Biological Attack to address the biological threat and to assess the role of the DHS in preventing bioterrorism in the US.
The report assesses the health aspects of the threat of biological and chemical weapons, including specific agents, focusing on civilian impacts. It then makes recommendations for preparedness and prevention of attacks.
In the wake of the 9/11 terrorist attacks, the Subcommittee of the Committee on Appropriations discusses US preparedness for a bioterrorism event in a series of hearings over a few weeks.
This report aims to make recommendations to medical and public health professionals for measures to be taken following the use of smallpox as a biological weapon against a civilian population.